Kanzhun Ltd ADRBZ
Price$14.95Intrinsic value$44.27196% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.2B+17.3% YoYTTM through 31 Dec 2025
Net Income $391.1M0.0% YoYTTM through 31 Dec 2025
Free Cash Flow $633.9MTTM through 31 Dec 2025

Margins

Current
Gross Margin85.1%
EBITDA Margin32.9%
Operating Margin29.8%
Net Margin33.1%

Returns

13.4%ROE
11.0%ROA
17.2%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio4.66x
Net Debt-$19.9Bnet cash position
Cash & Equivalents$587M

Quality Metrics

Altman Z-Score7.62
Piotroski F-Score6 / 9
FCF Margin53.6%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $8.3B
Diluted EPS$0.42TTM
'22'23'24'25
FY2025: $0.42

Dividend

$0.17Per share, FY20250.00%Yield

Capital Allocation

R&D Spend$236.5M
Capex Intensity1.4%
Financials converted at 6.9961 from RMB.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.